Robert Berman sold $7.5M worth of shares in Biohaven Pharmaceutical Holding Co., Ltd. in June 2018

Jul 08, 2018
Insider Transactions
Background Information
Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT.